SOLUTION BRIEF

Generative AI: transforming drug discovery with purpose-built tools

Download Now

Discover how generative AI is revolutionising drug development in the biopharma industry

Introduction

With drug discovery taking over a decade and costing billions, organisations face growing challenges in efficiency, data management, and innovation. 


This solution brief, from AWS and NVIDIA, explores how purpose-built AI models and AI-driven insights help identify drug candidates faster, optimise lead compounds, and reduce costly experimental work. 


Using advanced tools such as AWS HealthOmics and NVIDIA BioNeMo, biopharma companies can accelerate research, improve data analysis, and streamline workflows.

Download Now

Introduction

With drug discovery taking over a decade and costing billions, organisations face growing challenges in efficiency, data management, and innovation.

This solution brief, from AWS and NVIDIA, explores how purpose-built AI models and AI-driven insights help identify drug candidates faster, optimise lead compounds, and reduce costly experimental work.

Using advanced tools such as AWS HealthOmics and NVIDIA BioNeMo, biopharma companies can accelerate research, improve data analysis, and streamline workflows. 

Generative AI drives new opportunities

With drug discovery taking over a decade and costing billions, organisations face growing challenges in efficiency, data management, and innovation.

This solution brief, from AWS and NVIDIA, explores how purpose-built AI models and AI-driven insights help identify drug candidates faster, optimise lead compounds, and reduce costly experimental work.

Using advanced tools such as AWS HealthOmics and NVIDIA BioNeMo, biopharma companies can accelerate research, improve data analysis, and streamline workflows. .

Learn:

How generative AI accelerates early-stage drug discovery and reduces experimental costs

The role of AI in optimising target identification, protein design, and drug screening

How AI models improve data analysis, handling complex datasets from genomics to chemical structures

Ways to use AI for virtual screening and de novo drug design

How AI-powered tools improve predictive accuracy and minimise the risk of drug failure

Strategies to overcome challenges in integrating AI into existing drug discovery workflows

Download now to explore how you can harness generative AI for smarter, faster drug discovery

Download Now